Amanda Dalby
1 - 6 out of 6Page size: 10
Publications
- 2020
- Published
Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions
Amanda Dalby, Jeremy Pike, Neil Morgan & Steve Watson, 14 Jul 2020, In: Blood Advances. 4, 13, p. 2953–2961 9 p.Research output: Contribution to journal › Article › peer-review
- 2019
- Published
Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling
Amanda Dalby, 22 Aug 2019, In: Arteriosclerosis, Thrombosis, and Vascular Biology. 39, 11, p. 2289–2302Research output: Contribution to journal › Article › peer-review
- 2018
- Published
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision
Amanda Dalby, 11 Dec 2018, In: Stem Cell Reports. 11, 6, p. 1462-1478Research output: Contribution to journal › Article › peer-review
- Published
Anagrelide is an anti-megakaryocytic and not an anti-platelet agent
Steve Watson & Amanda Dalby, 7 Nov 2018, In: Platelets. p. 136-137Research output: Contribution to journal › Review article › peer-review
- E-pub ahead of print
- 2016
- Published
Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming
Amanda Dalby, Tatyana Ponomaryov, Alexander Brill & 2 others, , 1 Sep 2016, In: Nature Communications. 7, 1, 16 p., 11208.Research output: Contribution to journal › Article › peer-review